Cybersecurity breach costs in manufacturing surged to $5.55 million in 2024, a 17.5% increase. Hackers now see factories as lucrative targets, forcing builders and integrators to deliver pre-secured machines. The basics, from passwords to network zones, are no longer optional.
Meta has paused the international launch of its Meta Ray-Ban Display smart glasses in the UK, France, Italy, and Canada. The company says it needs to focus on fulfilling US orders first due to high demand and limited stock.
Japan is fighting back against manga piracy, which costs an estimated $55 billion annually. The government is funding AI translation training and developing tools to automatically find and shut down illegal sites.
At CES 2026, Asus is all-in on AI PCs with its new Zenbook lineup. The focus is on extreme portability paired with local AI processing, headlined by the Snapdragon-powered A-series and the innovative dual-screen Duo.
Roborock is finally entering the roller mop robot vacuum arena with the Qrevo Curv 2 Flow. The new model features a self-cleaning roller mop, 20,000Pa suction, and Matter support, launching January 19th for a discounted price of $849.
Researchers in China have published a study showing they achieved plasma densities far beyond what was thought possible. This breaks a long-standing barrier known as the Greenwald limit, a major hurdle for sustainable fusion power.
A growing number of judges are using AI to help write legal opinions and conduct research, despite high-profile blunders. The technology promises to ease massive backlogs, but its rapid adoption is forcing the courts to scramble for rules.
UK Tech Secretary Liz Kendall has directly intervened, calling on X to urgently address how its Grok AI is being used to create non-consensual sexual images. The media regulator Ofcom has now launched a formal probe into the platform.
LG just announced its fastest, brightest OLED gaming monitor yet. The 27-inch UltraGear GX7 boasts a 540Hz refresh rate and new Tandem OLED tech for improved brightness.
A patient has died from liver failure in a late-stage gene editing trial, prompting a full pause of related studies. This tragic event forces a critical moment of reckoning for CRISPR and the entire field of genetic medicine.
